|
HY-15030-500mg
|
MedChemexpress LLC
|
Naproxen [CAS 22204-53-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-15030-1mL
|
MedChemexpress LLC
|
Naproxen [CAS 22204-53-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-19675-10mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19675-100mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19675-25mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19675-5mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19675-50mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19675-1mL
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-127111-10mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-100mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-25mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-5mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-50mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-1mL
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0497S1-10mg
|
MedChemexpress LLC
|
Niclosamide-13C6 [CAS 1325808-64-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0497S1-5mg
|
MedChemexpress LLC
|
Niclosamide-13C6 [CAS 1325808-64-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-10mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-100mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-5mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-50mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-1mL
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-18874-1mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-10mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-100mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-25mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
